AAAAAA

   
Results: 1-20 |
Results: 20
BUZZ, HYPE...FOUNDATION
Authors: COLLINS NH
Citation: Nh. Collins, BUZZ, HYPE...FOUNDATION, Journal of hematotherapy, 7(5), 1998, pp. 401-401
T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION AS POSTREMISSION THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA - FREEDOM FROM RELAPSE IN THE ABSENCE OF GRAFT-VERSUS-HOST DISEASE
Authors: PAPADOPOULOS EB CARABASI MH CASTROMALASPINA H CHILDS BH MACKINNON S BOULAD F GILLIO AP KERNAN NA SMALL TN SZABOLCS P TAYLOR J YAHALOM J COLLINS NH BLEAU SA BLACK PM HELLER G OREILLY RJ YOUNG JW
Citation: Eb. Papadopoulos et al., T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION AS POSTREMISSION THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA - FREEDOM FROM RELAPSE IN THE ABSENCE OF GRAFT-VERSUS-HOST DISEASE, Blood, 91(3), 1998, pp. 1083-1090
A JOB WELL DONE
Authors: GEE AP COLLINS NH
Citation: Ap. Gee et Nh. Collins, A JOB WELL DONE, Journal of hematotherapy, 6(4), 1997, pp. 283-284
MULTINATIONAL, MULTICULTURAL, AND MULTIPROFESSIONAL LESSONS
Authors: COLLINS NH
Citation: Nh. Collins, MULTINATIONAL, MULTICULTURAL, AND MULTIPROFESSIONAL LESSONS, Journal of hematotherapy, 6(3), 1997, pp. 189-190
REPORT ON THE STANDARDIZATION OF CLONOGENEIC HEMATOPOIETIC PRECURSOR ASSAYS FOR THE UNRELATED DONOR BONE-MARROW TRANSPLANTATION TRIAL
Authors: KEEVERTAYLOR CA COLLINS NH CARTER S KELLEY L GEE A FULLER S
Citation: Ca. Keevertaylor et al., REPORT ON THE STANDARDIZATION OF CLONOGENEIC HEMATOPOIETIC PRECURSOR ASSAYS FOR THE UNRELATED DONOR BONE-MARROW TRANSPLANTATION TRIAL, Blood, 90(10), 1997, pp. 1639-1639
REDUCED ACUTE AND CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD) DO NOT COMPROMISE LEUKEMIA FREE SURVIVAL FOLLOWING T-CELL DEPLETED (SBA-E) UNRELATED MARROW TRANSPLANTS FOR PEDIATRIC ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: KERNAN NA BOULAD F GILLIO A SMALL T VANSYCKLE K SZABOLCS P COLLINS NH YANG SY LANDREY C MITCHELLGRANT J BLEAU S DUPONT B OREILLY RJ
Citation: Na. Kernan et al., REDUCED ACUTE AND CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD) DO NOT COMPROMISE LEUKEMIA FREE SURVIVAL FOLLOWING T-CELL DEPLETED (SBA-E) UNRELATED MARROW TRANSPLANTS FOR PEDIATRIC ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 88(10), 1996, pp. 1059-1059
SERUM GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) LEVELS AFTER ALLOGENEIC T-CELL-DEPLETED MARROW TRANSPLANTATION
Authors: PAPADAKIS V DIAZBARRIENTOS T HELLER G COLLINS NH MCKEEVER S KERNAN NA
Citation: V. Papadakis et al., SERUM GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) LEVELS AFTER ALLOGENEIC T-CELL-DEPLETED MARROW TRANSPLANTATION, Bone marrow transplantation, 15(6), 1995, pp. 955-961
ADOPTIVE IMMUNOTHERAPY USING DONOR LEUKOCYTES FOLLOWING BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - IS T-CELL DOSE IMPORTANTIN DETERMINING BIOLOGICAL RESPONSE
Authors: MACKINNON S PAPADOPOULOS EB CARABASI MH REICH L COLLINS NH OREILLY RJ
Citation: S. Mackinnon et al., ADOPTIVE IMMUNOTHERAPY USING DONOR LEUKOCYTES FOLLOWING BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - IS T-CELL DOSE IMPORTANTIN DETERMINING BIOLOGICAL RESPONSE, Bone marrow transplantation, 15(4), 1995, pp. 591-594
ADOPTIVE IMMUNOTHERAPY EVALUATING ESCALATING DOSES OF DONOR LEUKOCYTES FOR RELAPSE OF CHRONIC MYELOID-LEUKEMIA AFTER BONE-MARROW TRANSPLANTATION - SEPARATION OF GRAFT-VERSUS-LEUKEMIA RESPONSES FROM GRAFT-VERSUS-HOST DISEASE
Authors: MACKINNON S PAPADOPOULOS EB CARABASI MH REICH L COLLINS NH BOULAD F CASTROMALASPINA H CHILDS BH GILLIO AP KERNAN NA SMALL TN YOUNG JW OREILLY RJ
Citation: S. Mackinnon et al., ADOPTIVE IMMUNOTHERAPY EVALUATING ESCALATING DOSES OF DONOR LEUKOCYTES FOR RELAPSE OF CHRONIC MYELOID-LEUKEMIA AFTER BONE-MARROW TRANSPLANTATION - SEPARATION OF GRAFT-VERSUS-LEUKEMIA RESPONSES FROM GRAFT-VERSUS-HOST DISEASE, Blood, 86(4), 1995, pp. 1261-1268
LONG-TERM FOLLOW-UP OF RECIPIENTS OF HLA-MATCHED RELATED BONE-MARROW TRANSPLANTS DEPLETED OF T-CELLS BY SOYBEAN LECTIN AGGLUTINATION COMBINED WITH AIS CELLECTORS
Authors: CARABASI MH COLLINS NH SMALL TN CASTROMALASPINA H CHILDS BH MACKINNON S PAPADOPOULOS EB YOUNG JW LEBKOWSKI J OKARMA T VANHOEF M BLACK P OREILLY R
Citation: Mh. Carabasi et al., LONG-TERM FOLLOW-UP OF RECIPIENTS OF HLA-MATCHED RELATED BONE-MARROW TRANSPLANTS DEPLETED OF T-CELLS BY SOYBEAN LECTIN AGGLUTINATION COMBINED WITH AIS CELLECTORS, Blood, 86(10), 1995, pp. 366-366
IMPACT OF THIOTEPA AND DONOR LYMPHOCYTE INFUSIONS ON OUTCOME AFTER T-CELL-DEPLETED (TCD) ALLOGENEIC BMT IN PATIENTS WITH CHRONIC PHASE (CP)CML
Authors: CARABASI MH CASTROMALASPINA H CHILDS BH PAPADOPOULOS EB YOUNG JW COLLINS NH BLACK P OREILLY RJ
Citation: Mh. Carabasi et al., IMPACT OF THIOTEPA AND DONOR LYMPHOCYTE INFUSIONS ON OUTCOME AFTER T-CELL-DEPLETED (TCD) ALLOGENEIC BMT IN PATIENTS WITH CHRONIC PHASE (CP)CML, Blood, 86(10), 1995, pp. 2246-2246
DONOR LEUKOCYTE INFUSIONS FOR MOLECULAR OR CYTOGENETIC RELAPSE OF CMLFOLLOWING ALLOGENEIC BMT - GRAFT-VERSUS-LEUKEMIA RESPONSES WITH MINIMAL TOXICITY
Authors: MACKINNON S PAPADOPOULOS EB CARABASI MH REICH L COLLINS NH BOULAD F CASTROMALASPINA H CHILDS B GILLIO A KERNAN NA SMALL T YOUNG J OREILLY RJ
Citation: S. Mackinnon et al., DONOR LEUKOCYTE INFUSIONS FOR MOLECULAR OR CYTOGENETIC RELAPSE OF CMLFOLLOWING ALLOGENEIC BMT - GRAFT-VERSUS-LEUKEMIA RESPONSES WITH MINIMAL TOXICITY, Blood, 86(10), 1995, pp. 2251-2251
PREVENTION OF ACUTE AND CHRONIC GRAFT-VS-HOST DISEASE (GVHD) BY SBAE T-CELL DEPLETED MARROW GRAFTS - DOSE OF T-CELLS, QUANTITATED BY LIMITING DILUTION, DISTINGUISHES PATIENTS AT RISK OF GVHD FOLLOWING MATCHED RELATED BUT NOT MATCHED UNRELATED MARROW GRAFTS
Authors: COLLINS NH BLEAU S KERNAN NA BLACK P OREILLY RJ
Citation: Nh. Collins et al., PREVENTION OF ACUTE AND CHRONIC GRAFT-VS-HOST DISEASE (GVHD) BY SBAE T-CELL DEPLETED MARROW GRAFTS - DOSE OF T-CELLS, QUANTITATED BY LIMITING DILUTION, DISTINGUISHES PATIENTS AT RISK OF GVHD FOLLOWING MATCHED RELATED BUT NOT MATCHED UNRELATED MARROW GRAFTS, Blood, 86(10), 1995, pp. 2464-2464
T-CELL DEPLETION OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) BY EITHER CD34(-ROSETTE DEPLETION OR SEA AGGLUTINATION AND E-ROSETTE DEPLETION- COMPARISON OF T-CELL AND HEMATOPOIETIC-CELL PROGENITOR RECOVERY() SELECTION AND E)
Authors: FERNANDEZ JM YAN Y BLEAU S COLLINS NH OREILLY RJ
Citation: Jm. Fernandez et al., T-CELL DEPLETION OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) BY EITHER CD34(-ROSETTE DEPLETION OR SEA AGGLUTINATION AND E-ROSETTE DEPLETION- COMPARISON OF T-CELL AND HEMATOPOIETIC-CELL PROGENITOR RECOVERY() SELECTION AND E), Blood, 86(10), 1995, pp. 2491-2491
IMPROVED DISEASE-FREE SURVIVAL IN RECIPIENTS OF T CELL-DEPLETED (SBA-E-) BONE-MARROW ALLOGRAFTS FOR ACUTE NONLYMPHOCYTIC LEUKEMIA IN 1ST REMISSION
Authors: PAPADOPOULOS EB BOULAD F CARABASI MH CASTROMALASPINA H CHILDS BH COLLINS NH EMANUEL D GILLIO AP KERNAN NA MACKINNON S SMALL TN LINDSLEY K YAHALOM J BLEAU S BLACK P HELLER G OREILLY RJ YOUNG JW
Citation: Eb. Papadopoulos et al., IMPROVED DISEASE-FREE SURVIVAL IN RECIPIENTS OF T CELL-DEPLETED (SBA-E-) BONE-MARROW ALLOGRAFTS FOR ACUTE NONLYMPHOCYTIC LEUKEMIA IN 1ST REMISSION, Blood, 84(10), 1994, pp. 10000331-10000331
GROWTH OF EPSTEIN-BARR VIRUS-INDUCED HUMAN B-CELL LYMPHO-PROLIFERATIVE DISORDERS (EBV-LPD) IN MICE WITH SEVERE COMBINED IMMUNODEFICIENCY (SCID) IS FACILITATED BY DEPLETION OF MOUSE NATURAL-KILLER-CELL FUNCTIONWITH RABBIT ANTI-ASIALO GM1 ANTISERUM (ALPHA-ASIALO GM1)
Authors: LACERDA JF DENNIG D LADANYI M JAGIELLO C NGUYEN H COLLINS NH OREILLY RJ
Citation: Jf. Lacerda et al., GROWTH OF EPSTEIN-BARR VIRUS-INDUCED HUMAN B-CELL LYMPHO-PROLIFERATIVE DISORDERS (EBV-LPD) IN MICE WITH SEVERE COMBINED IMMUNODEFICIENCY (SCID) IS FACILITATED BY DEPLETION OF MOUSE NATURAL-KILLER-CELL FUNCTIONWITH RABBIT ANTI-ASIALO GM1 ANTISERUM (ALPHA-ASIALO GM1), Blood, 84(10), 1994, pp. 10000497-10000497
T-CELL RECOVERY DURING T-CELL DEPLETION OF HUMAN BONE-MARROW BY SBA-EOR SBA CD34+ SELECTION
Authors: FERNANDEZ JM COLLINS NH BERENSON R OREILLY RJ
Citation: Jm. Fernandez et al., T-CELL RECOVERY DURING T-CELL DEPLETION OF HUMAN BONE-MARROW BY SBA-EOR SBA CD34+ SELECTION, Blood, 84(10), 1994, pp. 10000500-10000500
ADOPTIVE IMMUNOTHERAPY USING ESCALATING DOSES OF DONOR LEUKOCYTES FORRELAPSED CHRONIC MYELOID-LEUKEMIA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: MACKINNON S PAPADOPOULOS EB CARABASI MH REICH L COLLINS NH BOULAD F CASTROMALASPINA H CHILDS B GILLIO A KERNAN NA SMALL T YOUNG J OREILLY RJ
Citation: S. Mackinnon et al., ADOPTIVE IMMUNOTHERAPY USING ESCALATING DOSES OF DONOR LEUKOCYTES FORRELAPSED CHRONIC MYELOID-LEUKEMIA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 84(10), 1994, pp. 10000538-10000538
SERUM G-CSF LEVELS POST T-CELL DEPLETED MARROW TRANSPLANT CORRELATE WITH THE ABSOLUTE NEUTROPHIL COUNT, RECIPIENT AGE AND BONE-MARROW CELL DOSE
Authors: PAPADAKIS V DIAZBARRIENTOS T COLLINS NH MCKEEVER S HELLER G KERNAN NA
Citation: V. Papadakis et al., SERUM G-CSF LEVELS POST T-CELL DEPLETED MARROW TRANSPLANT CORRELATE WITH THE ABSOLUTE NEUTROPHIL COUNT, RECIPIENT AGE AND BONE-MARROW CELL DOSE, Blood, 82(10), 1993, pp. 10000287-10000287
EVALUATION OF THE ANTILEUKEMIC ACTIVITY OF HUMAN LAK CELLS AND ALLOCYTOTOXIC T-CELLS IN SCID MICE BEARING FRESH HUMAN AML XENOGRAFTS
Authors: SALOMON O COLLINS NH NGUYEN H RODRIGUEZ E FALKENBERG F OREILLY RJ
Citation: O. Salomon et al., EVALUATION OF THE ANTILEUKEMIC ACTIVITY OF HUMAN LAK CELLS AND ALLOCYTOTOXIC T-CELLS IN SCID MICE BEARING FRESH HUMAN AML XENOGRAFTS, Blood, 82(10), 1993, pp. 10000307-10000307
Risultati: 1-20 |